SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reaching its 80th event triggered final analysis, putting the upcoming GPS topline readout at the center of discussion; the milestone does not reveal whether the treatment worked. The stocks sharp decline has sparked debate, with some traders calling it a sell-the-news shakeout or short-driven move, while others point to profit-taking and de-risking ahead of a binary result.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

Record quarterly results, a large shareholder-return plan, and SK Hynixs outlook for tight AI-memory supply are driving the rally. Traders are largely bullish on continued HBM and DRAM demand, though some flag memory-cycle risks and question whether the earnings are fully reflected in the share price.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Trian Fund and its partners proposed taking Wendys private, driving a sharp share-price jump. Traders are debating whether the offer undervalues the company and may be raised or draw competing bids, while others view it as a likely ceiling; no deal is confirmed.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphases earnings miss and much weaker-than-expected outlook have intensified concerns about soft residential solar demand amid high interest rates and the expiration of a tax credit. Most traders are bearish on the near-term outlook, though some see the selloff as a buying opportunity and cite the AI data-center transformer opportunity as a longer-term, still-distant growth prospect.

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Genmab - ADR

Positive Phase 3 cancer-trial results are driving GMABs sharp rally, with traders highlighting Rina-S data in ovarian cancer and petosemtamab results in head-and-neck cancer. The community is celebrating the pipeline progress, while some caution that the surge may price in successful commercialization and regulatory execution and could fade.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertivs quarterly results beat expectations, organic orders more than doubled, and the company raised its full-year outlook, reinforcing discussion of strong AI data-center power and cooling demand. Traders broadly cheered the report as evidence the buildout remains robust, while some cautioned against chasing the sharp post-earnings jump and watched for profit-taking.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention after short seller Culper Research alleged that its wafer-scale processors may have a limited operating life, raising questions about reliability and customer economics; traders dispute the unverified claims and accuse the short seller of seeking to pressure the stock. Upcoming share unlocks add to concerns about selling pressure, while some investors cite the Oracle cloud partnership as a positive counterpoint.

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Prime Medicine Inc

PRME is surging to 52-week highs, with traders pointing to breakout momentum and potential short covering. Some link the move to discussion of FDA guidance for rare-disease reviews, though any company-specific catalyst remains speculative; concerns about a possible share offering are also tempering enthusiasm.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernovas quarterly results beat expectations and its outlook was raised, alongside a planned Trench Group acquisition to expand its grid-equipment business. Traders are debating whether the deals cost and financing justify the post-report selloff, while others see a buying opportunity given strong power demand and backlog.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celesticas strong quarterly results and raised outlook, supported by robust AI and data-center hardware demand, are driving bullish attention and a sharp rebound after a steep pullback. Traders are debating whether the growth outlook outweighs concerns about reduced free-cash-flow guidance, thin margins, and the stocks volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPMorgan Chase & Co. Invests $2.33 Million in American Exceptionalism Acquisition Corp. $AEXA

JPMorgan Chase & Co. purchased a new position in American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the third quarter, according to its most recent 13F filing with the...

Polar Asset Management Partners Inc. Purchases New Position in American Exceptionalism Acquisition Corp. $AEXA

Polar Asset Management Partners Inc. acquired a new position in shares of American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,000,000...

American Exceptionalism Acquisition Corp.'s Lock-Up Period Will Expire on March 25th (NYSE:AEXA)

American Exceptionalism Acquisition's (NYSE:AEXA - Get Free Report) lock-up period is set to end on Wednesday, March 25th. American Exceptionalism Acquisition had issued 30,000,000 shares in its...

Moore Capital Management LP Buys New Position in American Exceptionalism Acquisition Corp. $AEXA

Moore Capital Management LP purchased a new position in American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) in the third quarter, according to the company in its most recent...

Linden Advisors LP Takes $9.29 Million Position in American Exceptionalism Acquisition Corp. $AEXA

Linden Advisors LP acquired a new position in American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the third quarter, according to the company in its most recent filing with the...

750,000 Shares in American Exceptionalism Acquisition Corp. $AEXA Bought by Lighthouse Investment Partners LLC

Lighthouse Investment Partners LLC bought a new position in shares of American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the 3rd quarter, according to its most recent...

Berkley W R Corp Acquires New Stake in American Exceptionalism Acquisition Corp. $AEXA

Berkley W R Corp bought a new position in shares of American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities...

Boothbay Fund Management LLC Buys New Position in American Exceptionalism Acquisition Corp. $AEXA

Boothbay Fund Management LLC purchased a new stake in American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the 3rd quarter, according to the company in its most recent filing...

Radcliffe Capital Management L.P. Invests $4.37 Million in American Exceptionalism Acquisition Corp. $AEXA

Radcliffe Capital Management L.P. purchased a new stake in American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the third quarter, according to the company in its most recent...

Harraden Circle Investments LLC Takes Position in American Exceptionalism Acquisition Corp. $AEXA

Harraden Circle Investments LLC bought a new position in shares of American Exceptionalism Acquisition Corp. (NYSE:AEXA - Free Report) during the 3rd quarter, according to its most recent 13F filing...

American Exceptionalism Acquisition Corp. A is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on July 11, 2025 and is headquartered in Menlo Park, CA.

American Exceptionalism Acquisition Corp. A - Ordinary Shares - Class A

Bearish Sentiment

50bps hike

25bps hike

No change

Rate cut

The Federal Reserve announces its rate decision Wednesday, October 28 at 2:00 PM ET, followed by Chair Kevin Warsh’s press conference at 2:30 PM, after raising rates by a quarter point to 3.75%-4.00% in September, its first hike since 2023. What do you think the Fed decides on Wednesday? Vote and explain your reasoning in the comments.

Current Price	$10.97
Prev Close	$10.85
Open	$10.84
Dividend Yield	0.00%
50-Day Moving Average	$11.17
Beta	0.09
Avg. Volume	73,173.45
PE Ratio	-366.55

52-Week High	$11.99
52-Week Low	$10.49
Market Capitalization	$536.65M
EPS (Annual)	-$0.1455
Price to Book	1.61
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

AEXA Fundamentals